Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Everett Meyer

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|September 18, 2025
Curing autoimmune diabetes with islet and hematopoietic cell transplantation after CD117 antibody-based conditioningPreksha Bhagchandani, Stephan A Ramos, Bianca Rodriguez, et al.
Elife|May 18, 2021
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonistCaleb R Glassman, Leon Su, Sonia S Majri-Morrison, et al.
The Journal of Clinical Investigation|November 18, 2025
Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody-based conditioningPreksha Bhagchandani, Stephan A Ramos, Bianca Rodriguez, et al.
Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.
Blood Cancer Journal|October 9, 2024
Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myelomaSurbhi Sidana, Andriyana K Bankova, Hitomi Hosoya, et al.
Blood Advances|August 25, 2021
Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipientsKent P Jensen, David A Hongo, XuHuai Ji, et al.
Science Translational Medicine|October 27, 2021
Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patientsPauline P Chen, Alma-Martina Cepika, Rajni Agarwal-Hashmi, et al.
Blood Advances|February 11, 2021
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphomaJohn H Baird, David J Epstein, John S Tamaresis, et al.
Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.
American Journal of Hematology|March 13, 2020
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effectsAnthony D Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|September 18, 2025
Curing autoimmune diabetes with islet and hematopoietic cell transplantation after CD117 antibody-based conditioningPreksha Bhagchandani, Stephan A Ramos, Bianca Rodriguez, et al.
Elife|May 18, 2021
Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonistCaleb R Glassman, Leon Su, Sonia S Majri-Morrison, et al.
The Journal of Clinical Investigation|November 18, 2025
Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody-based conditioningPreksha Bhagchandani, Stephan A Ramos, Bianca Rodriguez, et al.
Transplantation and Cellular Therapy|March 27, 2026
Superior Chronic GVHD-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell TransplantationAlfonso Molina, Quenton Rashawn Bubb, Hrishikesh K Srinagesh, et al.
Blood Cancer Journal|October 9, 2024
Phase II study of novel CXCR2 agonist and Plerixafor for rapid stem cell mobilization in patients with multiple myelomaSurbhi Sidana, Andriyana K Bankova, Hitomi Hosoya, et al.
Blood Advances|August 25, 2021
Development of immunosuppressive myeloid cells to induce tolerance in solid organ and hematopoietic cell transplant recipientsKent P Jensen, David A Hongo, XuHuai Ji, et al.
Science Translational Medicine|October 27, 2021
Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patientsPauline P Chen, Alma-Martina Cepika, Rajni Agarwal-Hashmi, et al.
Blood Advances|February 11, 2021
Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphomaJohn H Baird, David J Epstein, John S Tamaresis, et al.
Transplantation and Cellular Therapy|March 30, 2023
HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid LeukemiaRupa Narayan, Abhishek Niroula, Tao Wang, et al.
American Journal of Hematology|March 13, 2020
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effectsAnthony D Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, et al.
Pageof 5